Status:

COMPLETED

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

Lead Sponsor:

Abramson Cancer Center at Penn Medicine

Conditions:

Gastrointestinal Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Pharmacogenomics (PGx) is the study of how genes affect a person's response to drugs. PGx testing for certain genes can help predict the risk of side effects from chemotherapy agents. Testing is not r...

Eligibility Criteria

Inclusion

  • Able and willing to provide informed consent
  • Male or female, aged 18 years or older at the time of study initiation
  • Pathologically confirmed gastrointestinal malignancy for which treatment with a fluoropyrimidine and/or irinotecan is indicated
  • Willing to undergo blood or saliva sampling for PGx testing and comply with all study-related procedures
  • Life expectancy of at least 6 months

Exclusion

  • Prior treatment with irinotecan
  • DPYD or UGT1A1 genotype already known
  • Severe renal or hepatic impairment (or unacceptable laboratory values), including:
  • Neutrophil count of \<1.5 x 109/L, platelet count of \<100 x 109/L
  • Hepatic function as defined by serum bilirubin \>1.5 x upper limit of normal (ULN), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) \>2.5 x ULN, or in case of liver metastases ALT and AST\>5 x ULN
  • Renal function as defined by serum creatinine \>1.5 x ULN, or creatinine clearance \<60 ml/min (by Cockcroft-Gault Equation)
  • Women who are pregnant or breast feeding, or subjects who refuse to use reliable contraceptive methods throughout the study
  • Treating physician does not want subject to participate

Key Trial Info

Start Date :

March 26 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 9 2024

Estimated Enrollment :

552 Patients enrolled

Trial Details

Trial ID

NCT04736472

Start Date

March 26 2021

End Date

October 9 2024

Last Update

June 6 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Lancaster General Hospital

Lancaster, Pennsylvania, United States, 17604

2

Penn Presbyterian Medical Center

Philadelphia, Pennsylvania, United States, 19104

3

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104